Blood eosinophil percentage as a triage signal in pediatric allergic Rhinitis: Data-Driven cut-offs from a public cohort
View abstract on PubMed
Summary
This summary is machine-generated.Peripheral blood eosinophil percentage (Eos %) shows modest ability to triage children with allergic rhinitis (AR). While Eos % can aid in symptom burden assessment, it is insufficient alone for accurate diagnosis.
Area Of Science
- Pediatric Allergy and Immunology
- Clinical Diagnostics
- Biomarker Research
Background
- Clinicians require simple tools for triaging pediatric allergic rhinitis (AR) patients based on symptom burden.
- Peripheral blood eosinophil percentage (Eos %) was investigated as a potential triage biomarker.
Purpose Of The Study
- To evaluate the utility of Eos % thresholds for first-pass triage of children with AR.
- To determine if Eos % can effectively differentiate between high and low symptom burden in pediatric AR.
Main Methods
- Secondary analysis of a pediatric AR dataset including Eos % and Total Nasal Symptom Score (TNSS).
- Receiver Operating Characteristic (ROC) analysis and Area Under the Curve (AUC) calculation.
- Decision Curve Analysis (DCA) assessed clinical utility for triage thresholds.
Main Results
- Eos % demonstrated modest discrimination for high symptom burden (AUC 0.606).
- The optimal Youden cut-off was 6.8% Eos %, yielding suboptimal sensitivity (0.53) and specificity (0.68).
- Specific thresholds (∼3.7% for sensitivity, ∼8.5% for specificity) showed limited clinical utility.
Conclusions
- Eos % has limited discriminatory ability for AR triage in children.
- Eos % alone is inadequate for accurate triage and serves only as a complementary signal.
- Prospective validation is crucial due to weak performance and potential for false positives.

